NCT01673490View on ClinicalTrials.gov

Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia

PHASE4TerminatedINTERVENTIONAL

Enrollment

59

Participants

Timeline

Start Date

June 29, 2012

Primary Completion Date

March 20, 2015

Study Completion Date

March 20, 2015

Conditions

Prostatic Hyperplasia

Interventions

DRUG

Dutasteride/Tamsulosin

0.5 mg dutasteride/ 0.4 mg tamsulosin once daily for the duration of 180 day -treatment

Trial Locations (1)

Unknown

GSK Investigational Site, Ho Chi Minh City

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01673490 - Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia | Biotech Hunter | Biotech Hunter